These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37449648)

  • 1. Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study.
    Black E; Bruno R; Mammen K; Mills L; Siefried KJ; Deacon RM; Shakeshaft A; Dunlop AJ; Ezard N; Montebello M; Childs S; Reid D; Holmes J; Lintzeris N
    Med J Aust; 2023 Sep; 219(5):218-226. PubMed ID: 37449648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019.
    Black E; Mammen K; Deacon RM; Ezard N; Mills L; Dunlop AJ; Montebello M; Reid D; Childs S; Bruno R; Shakeshaft A; Siefried KJ; Farrell M; Holmes J; Lintzeris N
    Drug Alcohol Rev; 2023 Feb; 42(2):389-400. PubMed ID: 36524444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysubstance use in young people accessing residential and day-treatment services for substance use: substance use profiles, psychiatric comorbidity and treatment completion.
    Mefodeva V; Carlyle M; Walter Z; Chan G; Hides L
    Addiction; 2022 Dec; 117(12):3110-3120. PubMed ID: 35851706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality during and after specialist alcohol and other drug treatment: Variation in rates according to principal drug of concern and treatment modality.
    Havard A; Jones N; Bharat C; Gisev N; Pearson SA; Shakeshaft A; Farrell M; Degenhardt L
    Drug Alcohol Rev; 2023 Sep; 42(6):1461-1471. PubMed ID: 37186492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of polysubstance use and clinical comorbidity among persons seeking substance use treatment: An observational study.
    Ellis JD; Rabinowitz JA; Ware OD; Wells J; Dunn KE; Huhn AS
    J Subst Use Addict Treat; 2023 Mar; 146():208932. PubMed ID: 36880895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysubstance use in treatment seekers who inject amphetamine: Drug use profiles, injecting practices and quality of life.
    Kelly PJ; Robinson LD; Baker AL; Deane FP; McKetin R; Hudson S; Keane C
    Addict Behav; 2017 Aug; 71():25-30. PubMed ID: 28242532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance use during the COVID-19 pandemic: What is really happening?
    Mellos E; Paparrigopoulos T
    Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysubstance Use by Stimulant Users: Health Outcomes Over Three Years.
    Timko C; Han X; Woodhead E; Shelley A; Cucciare MA
    J Stud Alcohol Drugs; 2018 Sep; 79(5):799-807. PubMed ID: 30422794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the complexity, patterns, and correlates of alcohol and other substance use among young people seeking help for mental ill-health.
    Gao CX; Filia KM; Bedi G; Menssink JM; Brown E; Rickwood DJ; Parker AG; Hetrick SE; Herrman H; Hickie I; Telford N; McGorry PD; Cotton SM
    Soc Psychiatry Psychiatr Epidemiol; 2023 Oct; 58(10):1457-1467. PubMed ID: 36914881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of treatment provided for amphetamine use in New South Wales, Australia.
    McKetin R; Kelly E; Indig D
    Drug Alcohol Rev; 2005 Sep; 24(5):433-6. PubMed ID: 16298838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polysubstance use classes and health outcomes among women attending specialist substance use treatment services.
    Rodriguez AS; Robinson LD; Kelly PJ; Hudson S
    Drug Alcohol Rev; 2022 Feb; 41(2):488-500. PubMed ID: 34405938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment.
    Arendt M; Munk-Jørgensen P; Sher L; Jensen SO
    Drug Alcohol Depend; 2011 Apr; 114(2-3):134-9. PubMed ID: 20971585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the impacts of daily Cannabis versus alcohol and methamphetamines on young Australians in youth AOD treatment.
    Reichelt AC; Collett JC; Landmann O; Hallam KT
    BMC Psychiatry; 2019 Dec; 19(1):416. PubMed ID: 31870339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of individuals presenting to treatment for primary alcohol problems versus other drug problems in the Australian patient pathways study.
    Lubman DI; Garfield JB; Manning V; Berends L; Best D; Mugavin JM; Lam T; Buykx P; Larner A; Lloyd B; Room R; Allsop S
    BMC Psychiatry; 2016 Jul; 16():250. PubMed ID: 27435013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of drug-related hospital separations in Australia.
    Roxburgh A; Degenhardt L
    Drug Alcohol Depend; 2008 Jan; 92(1-3):149-55. PubMed ID: 17884302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring associations between early substance use and longitudinal socio-occupational functioning in young people engaged in a mental health service.
    Crouse JJ; Chitty KM; Iorfino F; White D; Nichles A; Zmicerevska N; Guastella AJ; Moustafa AA; Hermens DF; Scott EM; Hickie IB
    PLoS One; 2019; 14(1):e0210877. PubMed ID: 30653581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased demand for amphetamine treatment in rural Australia.
    Allan J; Ip RHL; Kemp M; Snowdon N
    Addict Sci Clin Pract; 2019 Apr; 14(1):13. PubMed ID: 30929641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    Castaldelli-Maia JM; Wang YP; Brunoni AR; Faro A; Guimarães RA; Lucchetti G; Martorell M; Moreira RS; Pacheco-Barrios K; Rodriguez JAB; Roever L; Silva DAS; Tovani-Palone MR; Valdez PR; Zimmermann IR; Culbreth GT; Hay SI; Murray CJL; Bensenor IM
    Lancet Psychiatry; 2023 Feb; 10(2):85-97. PubMed ID: 36697127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance Use and Co-occurring Physical Health Problems: File Review of a Residential Drug and Alcohol Treatment Service.
    Osborne B; Kelly PJ; Larance B; Robinson LD; Ivers R; Deane FP; Webber A; Kelly D
    J Dual Diagn; 2020; 16(2):250-259. PubMed ID: 31877110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.